Skip to content
drillr.ai
Sign up

000989.SZ

九芝堂

SZSE · Healthcare · C 制造业 · CN

CNY 8.66
−4.20%
Ask drillr

  • Aug 31, 2026, 21:41 UTC

    Jiuzhitang reported a 29.08% revenue increase in the first half of 2026, the highest among the 68 traditional medicine companies, while Zbd Pharmaceutical reported a 58.60% revenue decline, the lowest.

    Source:

  • Aug 19, 2026, 11:05 UTC

    Jiuzhitang announced its first-half 2026 results: revenue of 1.632 billion yuan, up 29.08% year-on-year; net profit attributable to shareholders of 250 million yuan, up 74.01%; non-GAAP net profit of 232 million yuan, up 70.36%. The company plans no cash dividend, no bonus shares, and no capital reserve conversion.

    Source: